Mehmet TÜRE, Meral YILDIZ, Mutlu KARKUCAK, Emine Tuna GÜLTEN, Deniz SIĞIRLI, Ahmet Tuncer ÖZMEN, Tahsin YAKUT

Investigation of TNF-alpha gene (G308A) and GSTP1 gene (Ile105Val) polymorphisms in Turkish patients with retinopathy of prematurity

Retinopathy of prematurity (ROP) is one of the most frequent causes of blindness in newborn babies. Currently, its etiology is not fully understood. In this study we aimed to investigate the correlation between a patient group with ROP and a control group in terms of the tumor necrosis factor-alpha (TNF-alpha) (G308A) gene and glutathione-S-transferase P1 (GSTP1) (Ile105Val) gene polymorphism. Materials and methods: Sixty-two patients diagnosed with ROP and 58 control subjects were included in this study. For TNF-alpha (G308A) gene and GSTP1 (Ile105Val) gene polymorphisms, the polymerase chain reaction-restriction fragment length polymorphism method was used. In statistical analysis the significance level was determined as P < 0.05. Results: When the patient and control groups were compared in terms of TNF-alpha (G308A) gene and GSTP1 (Ile105Val) gene polymorphisms, no statistically significant difference was found (P > 0.05). Conclusion: In our study, no correlation was identified between TNF-alpha (G308A) gene and GSTP1 (Ile105Val) gene polymorphisms and susceptibility for development of ROP. Further studies are required with more cases of ROP patients and other gene polymorphisms that could be related.

Anahtar Kelimeler:

TNF-alpha, GSTP1, gene polymorphism, retinopathy of prematurity

Investigation of TNF-alpha gene (G308A) and GSTP1 gene (Ile105Val) polymorphisms in Turkish patients with retinopathy of prematurity

Keywords:

TNF-alpha, GSTP1, gene polymorphism, retinopathy of prematurity,

PDF

___

Smith LE. Pathogenesis of retinopathy of prematurity. Acta Paediatr Suppl 2002; 91: 26–28.
Rusai K, Vannay A, Szebeni B, Borgulya G, Fekete A, Vásárhelyi B, Tulassay T, Szabó AJ. Endothelial nitric oxide synthase gene T-786C and 27-bp repeat gene polymorphisms in retinopathy of prematurity. Mol Vis 2008; 14: 286–290.
Subhani M, Combs A, Weber P, Gerontis C, DeCristofaro JD. Screening guidelines for retinopathy of prematurity: the need for revision in extremely low birth weight infants. Pediatrics 2001; 107: 656–659.
Karna P, Muttineni J, Angell L, Karmaus W. Retinopathy of prematurity and risk factors: a prospective cohort study. BMC Pediatr 2005; 5: 18.
Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore 2005; 34: 169–178.
Mohamed S, Schaa K, Cooper ME, Ahrens E, Alvarado A, Colaizy T, Marazita ML, Murray JC, Dagle JM. Genetic contributions to the development of retinopathy of prematurity. Pediatr Res 2009; 65: 193–197.
Inada M, Sato M, Morita S, Kitagawa K, Kawada K, Mitsuma A, Sawaki M, Fujita K, Ando Y. Associations between oxaliplatin- induced peripheral neuropathy and polymorphisms of the ERCC1 and GSTP1 genes. Int J Clin Pharmacol Ther 2010; 48: 729–734.
Hutcheson KA, Paluru PC, Bernstein SL, Koh J, Rappaport EF, Leach RA, Young TL. Norrie disease gene sequence variants in an ethnically diverse population with retinopathy of prematurity. Mol Vis 2005; 11: 501–508.
Shastry BS, Qu X. Lack of association of the VEGF gene promoter (-634 G→C and -460 C→T) polymorphism and the risk of advanced retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2007; 245: 741–743.
Kiran B, Karkucak M, Ozan H, Yakut T, Ozerkan K, Sag S, Ture M. GST (GSTM1, GSTT1, and GSTP1) polymorphisms in the genetic susceptibility of Turkish patients to cervical cancer. J Gynecol Oncol 2010; 21: 169–173.
García-Sáez I, Párraga A, Phillips MF, Mantle TJ, Coll M. Molecular structure at 1.8 Å of mouse liver class pi glutathione S-transferase complexed with S-(p-nitrobenzyl) glutathione and other inhibitors. J Mol Biol 1994; 237: 298–314.
Cilenšek I, Mankoč S, Petrovič MG, Petrovič D. GSTT1 null genotype is a risk factor for diabetic retinopathy in Caucasians with type 2 diabetes, whereas GSTM1 null genotype might confer protection against retinopathy. Dis Markers 2012; 32: 93–99.
Allen RG, Tresini M. Oxidative stress and gene regulation. Free Radic Biol Med 2000; 28: 463–499.
Yildiz M, Karkucak M, Yakut T, Gorukmez O, Ozmen A. Lack of association of genetic polymorphisms of angiotensin- converting enzyme gene I/D and glutathione-S-transferase enzyme T1 and M1 with retinopathy of prematures. Genet Mol Res 2010; 9: 2131–2139.
Qadri Q, Sameer AS, Shah ZA, Hamid A, Alam S, Manzoor S, Siddiqi MA. Genetic polymorphism of the glutathione- S-transferase P1 gene (GSTP1) and susceptibility to prostate cancer in the Kashmiri population. Genet Mol Res 2011; 10: 3038–3045.
Çalıkoglu M, Tamer L, Ates Aras N, Karakaş S, Ercan B. The association between polymorphic genotypes of glutathione S-transferases and COPD in the Turkish population. Biochem Genet 2006; 44: 307–319.
Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 2001; 104: 487–501.
Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, Marsh K, Kwiatkowski D. A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria. Nat Genet 1999; 22: 145–150.
Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 1997; 94: 3195–3199.
McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371: 508–510.
Wilson AG, di Giovine FS, Duff GW. Genetics of tumor necrosis factor-alpha in autoimmune, infectious, and neoplastic diseases. J Inflamm 1995; 45: 1–12.
Seidemann K, Zimmermann M, Book M, Meyer U, Burkhardt B, Welte K, Reiter A, Stanulla M. Tumor necrosis factor and lymphotoxin alpha genetic polymorphisms and outcome in pediatric patients with non-Hodgkin’s lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95. J Clin Oncol 2005; 23: 8414–8421.
Paine SK, Sen A, Choudhuri S, Mondal LK, Chowdhury IH, Basu A, Mukherjee A, Bhattacharya B. Association of tumor necrosis factor α, interleukin 6, and interleukin 10 promoter polymorphism with proliferative diabetic retinopathy in type 2 diabetic subjects. Retina 2012; 32: 1197–1203.
Abbas A, Delvinquiere K, Lechevrel M, Lebailly P, Gauduchon P, Launoy G, Sichel F. GSTM1, GSTT1, GSTP1 and CYP1A1 genetic polymorphisms and susceptibility to esophageal cancer in a French population: different pattern of squamous cell carcinoma and adenocarcinoma. World J Gastroenterol 2004; 10: 3389–3393.
Park K, Kim N, Nam J, Bang D, Lee ES. Association of TNFA promoter region haplotype in Behçet’s disease. J Korean Med Sci 2006; 21: 596–601.
Bizzarro MJ, Hussain N, Jonsson B, Feng R, Ment LR, Gruen JR, Zhang H, Bhandari V. Genetic susceptibility to retinopathy of prematurity. Pediatrics 2006; 118: 1858–1863.
Shastry BS, Pendergast SD, Hartzer MK, Liu X, Trese MT. Identification of missense mutations in the Norrie disease gene associated with advanced retinopathy of prematurity. Arch Ophthalmol 1997; 115: 651–655.
Haider MZ, Devarajan LV, Al-Essa M, Srivastva BS, Kumar H, Azad R, Rashwan N. Missense mutations in Norrie disease gene are not associated with advanced stages of retinopathy of prematurity in Kuwaiti Arabs. Biol Neonate 2000; 77: 88–91.
Haider MZ, Devarajan LV, Al-Essa M, Srivastva BS, Kumar H, Azad R, Rashwan N. Retinopathy of prematurity: mutations in the Norrie disease gene and the risk of progression to advanced stages. Pediatr Int 2001; 43: 120–123.
Kwinta P, Bik-Multanowski M, Mitkowska Z, Tomasik T, Pietrzyk JJ. The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1467–1475.
Bányász I, Bokodi G, Vannay A, Szebeni B, Treszl A, Vásárhelyi B, Tulassay T, Szabó A. Genetic polymorphisms of vascular endothelial growth factor and angiopoietin 2 in retinopathy of prematurity. Curr Eye Res 2006; 31: 685-690.
Shastry BS. Lack of association of VEGF (-2578 C→A) and ANG 2 (-35 G→C) gene polymorphisms with the progression of retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2009; 247: 859–860.
Balogh A, Derzbach L, Vannay A, Vásárhelyi B. Lack of association between insulin-like growth factor I receptor G (+3174)A polymorphism and retinopathy of prematurity. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1035–1038.
Shastry BS. Assessment of the contribution of insulin-like growth factor I receptor 3174 G→A polymorphism to the progression of advanced retinopathy of prematurity. Eur J Ophthalmol 2007; 17: 950–953.